FWP

$BSX · Boston Scientific Corporation

November 19, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

American Medical Systems Europe B.V., a subsidiary guaranteed by Boston Scientific Corporation, filed a free writing prospectus for a €4.25 billion senior notes offering. The filing details two euro-denominated tranches: a €500 million floating-rate note due December 1, 2028, paying three-month EURIBOR plus 63 basis points, and a €500 million fixed-rate note due the same date with a 3.875% coupon. Both tranches are expected to settle on December 1, 2026, and application will be made to list them on Euronext Dublin.

The floating-rate notes are not redeemable before maturity except for certain tax events, while the fixed-rate notes include a make-whole call at 15 basis points. The notes carry expected issuer ratings of A3 from Moody’s and A- from S&P and Fitch. Boston Scientific stated that net proceeds from this offering, together with a concurrent U.S. dollar notes offering, short-term borrowings, credit agreement borrowings, and cash on hand, will be used to finance the cash consideration for the Penumbra Acquisition and related fees and expenses, with any remainder available for general corporate purposes.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →